NR 566 / NR566
Final Exam Study Guide
Questions & Verified Answers
Advanced Pharmacology for Care of the Family
Latest Edition
Total Questions 150
Cognitive Mix 30% Recall • 50% Application • 20% Analysis
Question Style 75% Scenario-based • 25% Direct Recall
Sections 10 — PK/PD, Pharmacogenomics, Cardiovascular,
Respiratory, Endocrine, CNS, Infectious Disease,
GI/GU, Pain, Special Populations
Format 4-Option Multiple Choice (A–D) with Single Correct Answer
Aligned With 2026–2027 NR 566 Course Objectives and
Current Clinical Practice Guidelines
Examination Instructions:
This study guide is designed for Advanced Practice Registered Nurse (APRN) candidates preparing for the NR
566 Final Examination. Each question presents a clinical scenario reflecting primary care pharmacology practice
across the lifespan. Select the single best answer (A, B, C, or D). Verified answers and detailed rationales follow
each question, integrating mechanism of action, clinical guidelines, monitoring parameters, and prescriptive
decision-making at the APRN level.
Verified Answers with Detailed Rationales • 150 Questions Page 1
,NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
Section 1: Pharmacokinetics and Pharmacodynamics Across the Lifespan
Absorption, Distribution, Metabolism, Excretion, & Age-Related Considerations
Q1: A 78-year-old female is started on diazepam 5 mg at bedtime for insomnia. Four days later, she is brought to the
emergency department with prolonged sedation, confusion, and unsteady gait. Which pharmacokinetic change in
older adults best explains these findings?
A. Increased gastric pH leading to enhanced absorption of weak acids
B. Increased total body water and decreased adipose tissue resulting in lower Vd of lipophilic drugs
C. Decreased hepatic blood flow and reduced Phase I oxidative metabolism leading to drug
accumulation [CORRECT]
D. Enhanced glomerular filtration rate increasing renal clearance of active metabolites
Correct Answer: C
Rationale: Diazepam is a long-acting benzodiazepine that undergoes Phase I oxidative metabolism via CYP3A4 and
CYP2C19. Aging reduces hepatic blood flow by ~40% and decreases Phase I (oxidative) enzyme activity by ~30%, while
Phase II (conjugation) is relatively preserved. Combined with increased adipose tissue (higher Vd) and decreased renal
clearance of active metabolites (desmethyldiazepam, t1/2 up to 200 h), the drug accumulates, causing prolonged sedation,
falls, and delirium. Options A, B, and D describe changes opposite of what occurs in geriatric patients. Diazepam should
generally be avoided in older adults per the Beers Criteria; lorazepam or oxazepam (Phase II conjugation) are preferred.
Q2: A 6-week-old infant is prescribed phenobarbital for seizures. Compared with adults, which pharmacokinetic
parameter is most responsible for the need to administer higher weight-adjusted doses and longer dosing intervals to
achieve therapeutic levels?
A. Mature hepatic glucuronidation capacity present at birth
B. Higher percentage of total body water and extracellular fluid increasing the Vd of water-soluble
drugs [CORRECT]
C. Fully developed blood-brain barrier reducing CNS drug penetration
D. Adult-level GFR allowing rapid renal elimination of renally-cleared drugs
Correct Answer: B
Rationale: Neonates and young infants have a significantly higher percentage of total body water (~75-80% vs 60% in
adults) and a larger extracellular fluid compartment, which substantially increases the volume of distribution (Vd) of
water-soluble drugs like phenobarbital. To reach therapeutic plasma concentrations, larger weight-adjusted loading doses
are required. Hepatic glucuronidation is immature at birth (reaching adult levels by ~3-4 months), the blood-brain barrier is
incompletely developed (allowing greater CNS penetration, not less), and GFR is only ~30-40% of adult values at birth
(reaching adult levels by ~1 year). The longer dosing interval reflects longer elimination half-life due to immature
hepatic/renal clearance.
Q3: A 32-year-old pregnant patient at 28 weeks gestation requires pharmacologic treatment for hypertension. Which
physiologic change of pregnancy most directly influences the increased dose requirement for renally-cleared drugs
such as lamotrigine and labetalol?
A. Increased serum albumin leading to higher free drug fraction
B. Increased plasma volume and enhanced renal blood flow raising GFR by 50% [CORRECT]
C. Decreased cardiac output reducing drug delivery to the liver
D. Increased gastrointestinal motility decreasing drug absorption
Correct Answer: B
Verified Answers with Detailed Rationales • 150 Questions Page 2
,NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
Rationale: Pregnancy increases plasma volume by ~40-50%, cardiac output by ~30-40%, and renal plasma flow and GFR
by ~50-60% by the second trimester. This enhanced renal clearance significantly increases the dose requirement or dosing
frequency for renally-cleared drugs such as labetalol, lamotrigine (t1/2 decreases from ~25 to ~15 h), digoxin, and many
antibiotics. Serum albumin decreases (not increases), causing a higher free fraction for highly protein-bound drugs;
however, this does not increase dose requirements. GI motility is decreased, not increased, in pregnancy. Cardiac output
increases, not decreases. Lamotrigine often requires dose escalation in pregnancy and postpartum dose reduction to avoid
toxicity.
Q4: A provider prescribes a loading dose of a medication with a narrow therapeutic index. The patient has a Vd of
0.7 L/kg, target plasma concentration of 12 mg/L, and weighs 80 kg. Calculate the loading dose (LD).
A. 672 mg [CORRECT]
B. 960 mg
C. 560 mg
D. 840 mg
Correct Answer: A
Rationale: Loading dose formula: LD = Vd × Cp(target) × body weight. LD = 0.7 L/kg × 12 mg/L × 80 kg = 672 mg. The
loading dose is used to rapidly achieve therapeutic plasma concentration before steady state is reached (which takes 4-5
half-lives). Option B (960 mg) would result from a Vd of 1.0 L/kg, option C (560 mg) from a Vd of 0.58, and option D
(840 mg) from a Vd of 0.875. Loading doses are most clinically relevant for drugs with long half-lives (amiodarone,
digoxin, phenytoin) and narrow therapeutic index to rapidly achieve therapeutic effect.
Q5: Which statement best describes the concept of steady state and its clinical implications for drugs with a half-life
of 24 hours, when dosed once daily?
A. Steady state is reached in approximately 12 hours regardless of dosing interval
B. Steady state is reached in approximately 120 hours (5 half-lives), at which point the rate of drug
administration equals the rate of elimination [CORRECT]
C. Doubling the dose will halve the time to steady state
D. Steady state requires continuous IV infusion and cannot be achieved with oral dosing
Correct Answer: B
Rationale: Steady state is reached after approximately 4-5 half-lives regardless of route. For a drug with a t1/2 of 24 h
dosed once daily, steady state is reached in approximately 5 days (5 × 24 h = 120 h). At steady state, the rate of drug
administration equals the rate of elimination, and peak and trough concentrations remain consistent. Doubling the dose
increases steady state concentration proportionally but does NOT change time to steady state (which is determined solely
by half-life). Changing dosing frequency also does not affect time to steady state but does affect peak-trough fluctuation.
Loading doses can rapidly achieve therapeutic concentrations without waiting for steady state.
Q6: A drug has a half-life of 8 hours and is administered as a continuous IV infusion. How long will it take for the
drug to reach approximately 94% of steady-state concentration?
A. 16 hours (2 half-lives)
B. 24 hours (3 half-lives)
C. 32 hours (4 half-lives) [CORRECT]
D. 40 hours (5 half-lives)
Correct Answer: C
Rationale: The percentage of steady state reached is calculated as [1 - (0.5)^n] × 100, where n = number of half-lives.
After 1 half-life = 50%, 2 half-lives = 75%, 3 half-lives = 87.5%, 4 half-lives = 93.75% (≈94%), and 5 half-lives =
96.875% (≈97%). For a half-life of 8 hours, 94% steady state is reached after 4 half-lives = 32 hours. Clinically, 4-5
Verified Answers with Detailed Rationales • 150 Questions Page 3
, NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
half-lives is considered the practical time to steady state. This principle applies to all routes of administration and is critical
when assessing therapeutic response, evaluating efficacy, and timing drug level monitoring.
Q7: A 67-year-old male with cirrhosis and ascites is started on propranolol for portal hypertension prophylaxis.
Compared with healthy adults, which pharmacokinetic change most directly increases his risk of exaggerated
beta-blockade effects?
A. Increased first-pass metabolism leading to lower bioavailability
B. Decreased hepatic first-pass metabolism and reduced plasma protein binding increasing
bioavailability and free drug fraction [CORRECT]
C. Enhanced biliary excretion compensating for impaired hepatic metabolism
D. Increased hepatic blood flow accelerating drug clearance
Correct Answer: B
Rationale: Cirrhosis reduces hepatic first-pass metabolism (due to loss of functional hepatocyte mass and portosystemic
shunting), decreases synthesis of plasma proteins (albumin and alpha-1-acid glycoprotein), and reduces hepatic blood flow.
For highly extracted drugs like propranolol (>70% first-pass extraction), the result is substantially increased bioavailability
(up to 2-3x). For highly protein-bound drugs, decreased albumin increases free (active) drug fraction. The net effect is
increased pharmacodynamic effect even at standard doses. Dose reduction and careful titration are required. Options A, C,
and D are incorrect—cirrhosis decreases first-pass metabolism, reduces biliary excretion capacity, and decreases hepatic
blood flow.
Q8: A patient is taking warfarin 5 mg daily with a therapeutic INR of 2.5. The provider adds amiodarone 200 mg
daily for new-onset atrial fibrillation. One week later, the INR is 6.8 with epistaxis. Which
pharmacokinetic/pharmacodynamic mechanism best explains this interaction?
A. Amiodarone induces CYP2C9, increasing warfarin metabolism
B. Amiodarone inhibits CYP2C9 and CYP3A4, reducing warfarin clearance and increasing INR
[CORRECT]
C. Amiodarone displaces warfarin from plasma proteins only, transiently increasing INR
D. Amiodarone increases vitamin K absorption antagonizing warfarin
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 (the primary enzyme metabolizing the more potent S-enantiomer
of warfarin) and CYP3A4 (metabolizes the R-enantiomer), as well as P-glycoprotein. This inhibition reduces warfarin
clearance significantly, prolonging the half-life and dramatically increasing INR. The interaction is significant because
amiodarone has an extremely long half-life (~100 days) and the interaction can persist for weeks to months after
amiodarone discontinuation. Protein displacement alone would cause only transient (24-48 h) increases in INR. The
recommended warfarin dose reduction when amiodarone is initiated is 25-50%, with frequent INR monitoring. This is one
of the most clinically significant drug interactions in primary care.
Q9: Which of the following best describes the concept of a drug's therapeutic index (TI) and its clinical relevance?
A. TI = ED50/LD50; a higher TI indicates a higher risk of toxicity at therapeutic doses
B. TI = TD50/ED50; a lower TI indicates a narrower margin of safety and requires closer monitoring
[CORRECT]
C. TI = LD50/ED50; a higher TI indicates more effective drug with wider safety margin
D. TI is calculated from peak concentration divided by trough concentration
Correct Answer: B
Rationale: Therapeutic index (TI) is classically defined as TD50/ED50 (toxic dose in 50% of population divided by
effective dose in 50% of population). A lower TI (e.g., warfarin, digoxin, lithium, phenytoin) indicates a narrow margin
Verified Answers with Detailed Rationales • 150 Questions Page 4
Final Exam Study Guide
Questions & Verified Answers
Advanced Pharmacology for Care of the Family
Latest Edition
Total Questions 150
Cognitive Mix 30% Recall • 50% Application • 20% Analysis
Question Style 75% Scenario-based • 25% Direct Recall
Sections 10 — PK/PD, Pharmacogenomics, Cardiovascular,
Respiratory, Endocrine, CNS, Infectious Disease,
GI/GU, Pain, Special Populations
Format 4-Option Multiple Choice (A–D) with Single Correct Answer
Aligned With 2026–2027 NR 566 Course Objectives and
Current Clinical Practice Guidelines
Examination Instructions:
This study guide is designed for Advanced Practice Registered Nurse (APRN) candidates preparing for the NR
566 Final Examination. Each question presents a clinical scenario reflecting primary care pharmacology practice
across the lifespan. Select the single best answer (A, B, C, or D). Verified answers and detailed rationales follow
each question, integrating mechanism of action, clinical guidelines, monitoring parameters, and prescriptive
decision-making at the APRN level.
Verified Answers with Detailed Rationales • 150 Questions Page 1
,NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
Section 1: Pharmacokinetics and Pharmacodynamics Across the Lifespan
Absorption, Distribution, Metabolism, Excretion, & Age-Related Considerations
Q1: A 78-year-old female is started on diazepam 5 mg at bedtime for insomnia. Four days later, she is brought to the
emergency department with prolonged sedation, confusion, and unsteady gait. Which pharmacokinetic change in
older adults best explains these findings?
A. Increased gastric pH leading to enhanced absorption of weak acids
B. Increased total body water and decreased adipose tissue resulting in lower Vd of lipophilic drugs
C. Decreased hepatic blood flow and reduced Phase I oxidative metabolism leading to drug
accumulation [CORRECT]
D. Enhanced glomerular filtration rate increasing renal clearance of active metabolites
Correct Answer: C
Rationale: Diazepam is a long-acting benzodiazepine that undergoes Phase I oxidative metabolism via CYP3A4 and
CYP2C19. Aging reduces hepatic blood flow by ~40% and decreases Phase I (oxidative) enzyme activity by ~30%, while
Phase II (conjugation) is relatively preserved. Combined with increased adipose tissue (higher Vd) and decreased renal
clearance of active metabolites (desmethyldiazepam, t1/2 up to 200 h), the drug accumulates, causing prolonged sedation,
falls, and delirium. Options A, B, and D describe changes opposite of what occurs in geriatric patients. Diazepam should
generally be avoided in older adults per the Beers Criteria; lorazepam or oxazepam (Phase II conjugation) are preferred.
Q2: A 6-week-old infant is prescribed phenobarbital for seizures. Compared with adults, which pharmacokinetic
parameter is most responsible for the need to administer higher weight-adjusted doses and longer dosing intervals to
achieve therapeutic levels?
A. Mature hepatic glucuronidation capacity present at birth
B. Higher percentage of total body water and extracellular fluid increasing the Vd of water-soluble
drugs [CORRECT]
C. Fully developed blood-brain barrier reducing CNS drug penetration
D. Adult-level GFR allowing rapid renal elimination of renally-cleared drugs
Correct Answer: B
Rationale: Neonates and young infants have a significantly higher percentage of total body water (~75-80% vs 60% in
adults) and a larger extracellular fluid compartment, which substantially increases the volume of distribution (Vd) of
water-soluble drugs like phenobarbital. To reach therapeutic plasma concentrations, larger weight-adjusted loading doses
are required. Hepatic glucuronidation is immature at birth (reaching adult levels by ~3-4 months), the blood-brain barrier is
incompletely developed (allowing greater CNS penetration, not less), and GFR is only ~30-40% of adult values at birth
(reaching adult levels by ~1 year). The longer dosing interval reflects longer elimination half-life due to immature
hepatic/renal clearance.
Q3: A 32-year-old pregnant patient at 28 weeks gestation requires pharmacologic treatment for hypertension. Which
physiologic change of pregnancy most directly influences the increased dose requirement for renally-cleared drugs
such as lamotrigine and labetalol?
A. Increased serum albumin leading to higher free drug fraction
B. Increased plasma volume and enhanced renal blood flow raising GFR by 50% [CORRECT]
C. Decreased cardiac output reducing drug delivery to the liver
D. Increased gastrointestinal motility decreasing drug absorption
Correct Answer: B
Verified Answers with Detailed Rationales • 150 Questions Page 2
,NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
Rationale: Pregnancy increases plasma volume by ~40-50%, cardiac output by ~30-40%, and renal plasma flow and GFR
by ~50-60% by the second trimester. This enhanced renal clearance significantly increases the dose requirement or dosing
frequency for renally-cleared drugs such as labetalol, lamotrigine (t1/2 decreases from ~25 to ~15 h), digoxin, and many
antibiotics. Serum albumin decreases (not increases), causing a higher free fraction for highly protein-bound drugs;
however, this does not increase dose requirements. GI motility is decreased, not increased, in pregnancy. Cardiac output
increases, not decreases. Lamotrigine often requires dose escalation in pregnancy and postpartum dose reduction to avoid
toxicity.
Q4: A provider prescribes a loading dose of a medication with a narrow therapeutic index. The patient has a Vd of
0.7 L/kg, target plasma concentration of 12 mg/L, and weighs 80 kg. Calculate the loading dose (LD).
A. 672 mg [CORRECT]
B. 960 mg
C. 560 mg
D. 840 mg
Correct Answer: A
Rationale: Loading dose formula: LD = Vd × Cp(target) × body weight. LD = 0.7 L/kg × 12 mg/L × 80 kg = 672 mg. The
loading dose is used to rapidly achieve therapeutic plasma concentration before steady state is reached (which takes 4-5
half-lives). Option B (960 mg) would result from a Vd of 1.0 L/kg, option C (560 mg) from a Vd of 0.58, and option D
(840 mg) from a Vd of 0.875. Loading doses are most clinically relevant for drugs with long half-lives (amiodarone,
digoxin, phenytoin) and narrow therapeutic index to rapidly achieve therapeutic effect.
Q5: Which statement best describes the concept of steady state and its clinical implications for drugs with a half-life
of 24 hours, when dosed once daily?
A. Steady state is reached in approximately 12 hours regardless of dosing interval
B. Steady state is reached in approximately 120 hours (5 half-lives), at which point the rate of drug
administration equals the rate of elimination [CORRECT]
C. Doubling the dose will halve the time to steady state
D. Steady state requires continuous IV infusion and cannot be achieved with oral dosing
Correct Answer: B
Rationale: Steady state is reached after approximately 4-5 half-lives regardless of route. For a drug with a t1/2 of 24 h
dosed once daily, steady state is reached in approximately 5 days (5 × 24 h = 120 h). At steady state, the rate of drug
administration equals the rate of elimination, and peak and trough concentrations remain consistent. Doubling the dose
increases steady state concentration proportionally but does NOT change time to steady state (which is determined solely
by half-life). Changing dosing frequency also does not affect time to steady state but does affect peak-trough fluctuation.
Loading doses can rapidly achieve therapeutic concentrations without waiting for steady state.
Q6: A drug has a half-life of 8 hours and is administered as a continuous IV infusion. How long will it take for the
drug to reach approximately 94% of steady-state concentration?
A. 16 hours (2 half-lives)
B. 24 hours (3 half-lives)
C. 32 hours (4 half-lives) [CORRECT]
D. 40 hours (5 half-lives)
Correct Answer: C
Rationale: The percentage of steady state reached is calculated as [1 - (0.5)^n] × 100, where n = number of half-lives.
After 1 half-life = 50%, 2 half-lives = 75%, 3 half-lives = 87.5%, 4 half-lives = 93.75% (≈94%), and 5 half-lives =
96.875% (≈97%). For a half-life of 8 hours, 94% steady state is reached after 4 half-lives = 32 hours. Clinically, 4-5
Verified Answers with Detailed Rationales • 150 Questions Page 3
, NR 566 — Advanced Pharmacology for Care of the Family Final Exam Study Guide • 2026/2027
half-lives is considered the practical time to steady state. This principle applies to all routes of administration and is critical
when assessing therapeutic response, evaluating efficacy, and timing drug level monitoring.
Q7: A 67-year-old male with cirrhosis and ascites is started on propranolol for portal hypertension prophylaxis.
Compared with healthy adults, which pharmacokinetic change most directly increases his risk of exaggerated
beta-blockade effects?
A. Increased first-pass metabolism leading to lower bioavailability
B. Decreased hepatic first-pass metabolism and reduced plasma protein binding increasing
bioavailability and free drug fraction [CORRECT]
C. Enhanced biliary excretion compensating for impaired hepatic metabolism
D. Increased hepatic blood flow accelerating drug clearance
Correct Answer: B
Rationale: Cirrhosis reduces hepatic first-pass metabolism (due to loss of functional hepatocyte mass and portosystemic
shunting), decreases synthesis of plasma proteins (albumin and alpha-1-acid glycoprotein), and reduces hepatic blood flow.
For highly extracted drugs like propranolol (>70% first-pass extraction), the result is substantially increased bioavailability
(up to 2-3x). For highly protein-bound drugs, decreased albumin increases free (active) drug fraction. The net effect is
increased pharmacodynamic effect even at standard doses. Dose reduction and careful titration are required. Options A, C,
and D are incorrect—cirrhosis decreases first-pass metabolism, reduces biliary excretion capacity, and decreases hepatic
blood flow.
Q8: A patient is taking warfarin 5 mg daily with a therapeutic INR of 2.5. The provider adds amiodarone 200 mg
daily for new-onset atrial fibrillation. One week later, the INR is 6.8 with epistaxis. Which
pharmacokinetic/pharmacodynamic mechanism best explains this interaction?
A. Amiodarone induces CYP2C9, increasing warfarin metabolism
B. Amiodarone inhibits CYP2C9 and CYP3A4, reducing warfarin clearance and increasing INR
[CORRECT]
C. Amiodarone displaces warfarin from plasma proteins only, transiently increasing INR
D. Amiodarone increases vitamin K absorption antagonizing warfarin
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 (the primary enzyme metabolizing the more potent S-enantiomer
of warfarin) and CYP3A4 (metabolizes the R-enantiomer), as well as P-glycoprotein. This inhibition reduces warfarin
clearance significantly, prolonging the half-life and dramatically increasing INR. The interaction is significant because
amiodarone has an extremely long half-life (~100 days) and the interaction can persist for weeks to months after
amiodarone discontinuation. Protein displacement alone would cause only transient (24-48 h) increases in INR. The
recommended warfarin dose reduction when amiodarone is initiated is 25-50%, with frequent INR monitoring. This is one
of the most clinically significant drug interactions in primary care.
Q9: Which of the following best describes the concept of a drug's therapeutic index (TI) and its clinical relevance?
A. TI = ED50/LD50; a higher TI indicates a higher risk of toxicity at therapeutic doses
B. TI = TD50/ED50; a lower TI indicates a narrower margin of safety and requires closer monitoring
[CORRECT]
C. TI = LD50/ED50; a higher TI indicates more effective drug with wider safety margin
D. TI is calculated from peak concentration divided by trough concentration
Correct Answer: B
Rationale: Therapeutic index (TI) is classically defined as TD50/ED50 (toxic dose in 50% of population divided by
effective dose in 50% of population). A lower TI (e.g., warfarin, digoxin, lithium, phenytoin) indicates a narrow margin
Verified Answers with Detailed Rationales • 150 Questions Page 4
